Literature summary for 3.4.11.3 extracted from

Shibata, K.; Kajiyama, H.; Mizokami, Y.; Ino, K.; Nomura, S.; Mizutani, S.; Terauchi, M.; Kikkawa, F.
Placental leucine aminopeptidase (P-LAP) and glucose transporter 4 (GLUT4) expression in benign, borderline, and malignant ovarian epithelia (2005), Gynecol. Oncol., 98, 11-18.

Search for more literature for 3.4.11.3

Application

Application	Comment	Organism
medicine	P-LAP is available for evaluation of avarian epithelial malignancy and also as target for molecular therapy	Homo sapiens

Organism

Organism	UniProt	Comment	Textmining
Homo sapiens	-	-	-

Source Tissue

Source Tissue	Comment	Organism	Textmining
clear cell adenocarcinoma cell	P-LAP is detected in all clear-cell adenocarcinomas	Homo sapiens	-
cystadenoma cell	P-LAP is detected in 2 of 11 benign cystadenomas	Homo sapiens	-
endometrioid adenocarcinoma cell	P-LAP is detected in 15 of 17 endometrioid adenocarcinomas	Homo sapiens	-
mucinous adenocarcinoma cell	P-LAP is detected in 13 of 14 mucinous adenocarcinomas	Homo sapiens	-
ovarian borderline malignant tumor cell	P-LAP is detected in 7 of 14 borderline tumors	Homo sapiens	-
serous adenocarcinoma cell	tendency towards increased P-LAP expression with advancing grade is observed in serous adenocarcinomas	Homo sapiens	-

Synonyms

Synonyms	Comment	Organism
P-LAP	-	Homo sapiens
Placental leucine aminopeptidase	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)